OCT 10, 2019 6:00 AM PDT

Highly-efficient and -specific genome editing with Cas9 nickase ribonucleoproteins in Primary T-cells

Sponsored by: MilliporeSigma
Speaker

Abstract

In this webinar, we will be discussing some of our most recent testing using our Cas9 proteins, Cas9 RNP nickases in a variety of human cell types, including primary T-cells. Cas nucleases when delivered in protein format, pre-complexed with a single, modified guide RNA (gRNA), rather than encoded on a plasmid, allow researchers to bypass the historically limiting factors of using CRISPR in the therapeutic realm of off-targeting effects, low efficiency, and undesired cellular responses to foreign DNA. Modifying that Cas9 nuclease into a nickase with only a single active cutting domain, and then delivering two with proximal guide RNAs in a pair allows precise double stranded breaks, and provides hyper-specific and efficient genome editing in cell types that are more difficult to edit in.

CRISPR/Cas technologies have unlocked vast genome editing possibilities in human cell lines but have been historically limited in the therapeutic realm by off-targeting effects, low efficiency, and undesired cellular responses to foreign DNA plasmids. Recent advancements to combat these limitations include the direct delivery of ribonucleoproteins (RNPs) to cells. In this method, Cas nucleases are delivered in protein format, pre-complexed with a single, modified guide RNA (gRNA), rather than encoded on a plasmid. Another recent advancement is the use of paired Cas9 nickase systems. A nickase is a modified Cas9 nuclease with only one active cutting domain, allowing it to create single-stranded nicks in its target DNA. To achieve a double-stranded break (DSB), nickases must utilize two individual gRNAs targeting proximal DNA sequences, making an off-target DSB nearly impossible. Here, we combine these two innovations, enabling highly-efficient editing in human cells, without observable off-target effects, via the use of paired-nickase Cas9 RNPs. The improvements this system makes on previous methods lends to greater exploration of CRISPR technologies in the therapeutic domain

Learning Objectives:

1. Advantages of RNPs in Primary Cells

2. Nickase Design

3. Therapeutic Implications of this design


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
MAR 02, 2022 9:00 AM PST
C.E. CREDITS
MAR 02, 2022 9:00 AM PST
Date: March 02, 2022 Time: 9:00am (PST), 12:00pm (EST) Single cell RNA-seq is known to only capture a small fraction of the transcriptome of each cell. Often, this is due to inherent limitat...
LIVE NOW!
LIVE NOW!
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
OCT 10, 2019 6:00 AM PDT

Highly-efficient and -specific genome editing with Cas9 nickase ribonucleoproteins in Primary T-cells

Sponsored by: MilliporeSigma


Show Resources
Loading Comments...
Show Resources